Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Genetics of Hepatitis C Virus Infection

NCT00005657

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

NCT00537537

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +25 more
Locations: Novartis Investigative Site Hyderabad, India

Novartis Investigative Site Mumbai, India

Novartis Investigative Site Vellore, India

View Trial Details

Completed

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

NCT00467545

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Novartis Investigative Site (705-035) Daegu, South Korea

Novartis Investigative Site , (420-717) Gyeonggi-do, South Korea

Novartis Investigative Site , (405-760) Incheon, South Korea

Novartis Investigative Site , (136-705) Seoul, South Korea

View Trial Details

Completed

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

NCT00646503

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Novartis Investigative Site Beijing, China

View Trial Details

Completed

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

NCT03188276

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects

NCT01480622

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Shanghai, China

View Trial Details

Completed

The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

NCT03180333

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Nanjing First Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Combination Therapy for Chronic Hepatitis C Infection

NCT01805882

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Unity Health Care, Inc./DC General Washington D.C., District of Columbia, United States

Family Medical and Conseling Services Washington D.C., District of Columbia, United States

National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

NCT03173599

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Renji Hospital Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Completed

Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States

NCT00936715

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Los Angeles, California, United States

San Francisco, California, United States

Miami, Florida, United States

New York, United States

View Trial Details

Hepatitis, Chronic

Hepatitis, Chronic trial results

Related conditions